![]() ![]() The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). Our system takes these estimate changes into account and delivers a clear, actionable rating model. We developed the Zacks Rank to capitalize on this phenomenon. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.īased on our research, we believe these estimate revisions are directly related to near-team stock moves. These revisions help to show the ever-changing nature of near-term business trends. Investors should also note any recent changes to analyst estimates for CRISPR Therapeutics AG. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $12.18 million, down 5.6% from the year-ago period. The company is expected to report EPS of -$2.32, down 26.09% from the prior-year quarter. Investors will be hoping for strength from CRISPR Therapeutics AG as it approaches its next earnings release. Heading into today, shares of the company had gained 3.14% over the past month, outpacing the Medical sector's loss of 1.11% and lagging the S&P 500's gain of 3.6% in that time. Meanwhile, the Dow lost 0.46%, and the Nasdaq, a tech-heavy index, added 3.16%. ![]() This change lagged the S&P 500's daily loss of 0.03%. The establishment of a Safer Roads Fund to maximise travel on 3-star or better roads can provide international finance institutions, health organisations, treasury officials, road executives and road builders with the social and economic basis for safer, sustainable roads.CRISPR Therapeutics AG ( CRSP Quick Quote CRSP - Free Report) closed at $50.87 in the latest trading session, marking a -1.24% move from the prior day. The UN Secretary General has recommended all new roads should be built to a 3-star or better standard and existing roads upgraded. Now, the challenge is to build on this momentum. This game-changing move put road deaths centre stage – where they belong – as a global development issue, alongside poverty reduction targets and the right to clean water. In 2015, the United Nations included halving road deaths and serious injuries as a Sustainable Development Goal (3.6). IRAP and its partners are working with international bodies, national governments and highways agencies to build a global policy consensus for safer roads. ![]() We need a strong policy framework and ambitious global targets if we are to deliver safer roads that save people’s lives. Let’s work together to create a safer, better world! iRAP provides the business case for investment and the tools to maximise lives saved. Upgrading existing roads to maximise travel on 3-star or better roads is also practical, cost-effective and starts saving lives right away. This creates exciting opportunities for roads professionals and the road safety community to work together to save lives.īuilding all new roads to a 3-star or better standard for all road users saves lives and makes great business sense. Safer roads are becoming the new policy norm for investors and development agencies worldwide. Safer roads that save money! A win-win-win for all. Roads that deliver safer journeys for all users. We work worldwide with road management professionals to deliver safer roads for today and for the future. IRAP is an international leader in providing policy, investment and performance tracking tools for road executives, managers, engineers, designers and construction teams to build and maintain safer roads. Do you manage, design, build or maintain roads?
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |